FTC Focus: Exploring The Meaning Of Orange Book Letters

By Colin Kass and David Munkittrick · May 31, 2024, 5:00 PM EDT

This article is part of a monthly column that considers the significance of recent FTC antitrust announcements. In this installment, we discuss the agency's added scrutiny on pharmaceutical manufacturers' improper or inaccurate...

To view the full article, register now.